9 of 10

6 March 2025

AI in Life Sciences – 9 of 10 Insights

Navigating IP in AI due diligence

As AI models evolve over time, specific considerations will need to be incorporated into any due diligence. These include whether the solution is licensed-in to be licensed-out and has been pretrained/trained with third party or customer data.

  • Quick read
More
Author
Marc Shuler

Marc Schuler

Partner

Read More
Synapse

Back to

Synapse

Back to Synapse